August 2020 – Proactive Investors: One2One Virtual Conference

https://youtu.be/HjMglJPChJA

Preliminary Results Presentation for the year ended 31 March 2020

To view the presentation of the preliminary results for the year ended 31 March 2020 please click here.

Association for research in vision and ophthalmology (ARVO) annual meeting 2019 : Jason Commander presentation

To view the presentation please click here…

Proactive Investors ‘ReNeuron provides encouraging update to phase II eye disease trial’

https://youtu.be/ADBu4Uy7ZZ0

Proactive Investors ‘ReNeuron Group’s phase IIb stroke trial kicks off with first patient treated’

OIS: Ophthalmology Innovation & Investment – ReNeuron using hRPCs to treat inherited retinal degenerative diseases

Proactive Investors: Michael Hunt discusses very encouraging long-term stroke data

https://www.youtube.com/watch?v=7R4JluRuyKE

Proactive Investors: ReNeuron gears up for Phase III stroke disability study

https://youtu.be/QJaKk3F-TQs

Preliminary results presentation webcast 2017

Please click on link below for the webcast of the 2017 preliminary results presentation.

Proactive Investors: ReNeuron ‘greatly encouraged’ by US regulator feedback on CTX cell therapy trial

To view the full article click here…